Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03222037 · ClinicalTrials.gov registry record · Phase 4
Evaluation of Electronic LogMar Visual Acuity and Contrast Sensitivity in a Population of Contact Lens Wearers
A Phase 4 study, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- Phase 4
- Development phase
- 49
- Enrollment target
NCT03222037 is a Phase 4 study that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 49 participants.
The verdict
NCT03222037, a Phase 4 study, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 49 participants
- Enrollment target
Study Summary
This is a bilateral, non-dispensing, randomized, cross-over, single-masked study. There are a total of 3 visits where all study endpoints will be measured in all subjects at baseline with habitual lenses and under the two testing treatments sequentially in separate visits based on the randomization scheme
Interventions
- DEVICE Control
- DEVICE senofilcon A
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2017-06-27 |
| Est. Completion | 2017-08-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03222037
The ClinicalTrials.gov registry entry for NCT03222037 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT03222037 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03222037 about?
NCT03222037 is a clinical study titled "Evaluation of Electronic LogMar Visual Acuity and Contrast Sensitivity in a Population of Contact Lens Wearers". This is a bilateral, non-dispensing, randomized, cross-over, single-masked study. There are a total of 3 visits where all study endpoints will be measured in all subjects at baseline with habitual lenses and under the two testing treatments sequentially in separate visits based on the randomization ...
What is the current status of trial NCT03222037?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 49 participants. The study started on 2017-06-27. Estimated completion is 2017-08-04.
What interventions are being tested in trial NCT03222037?
The interventions under investigation include: Control (DEVICE), senofilcon A (DEVICE).
Who is sponsoring clinical trial NCT03222037?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.